Edward E. Hodgkin is no longer serving in their board position at Autolus Ltd.

Jul 05, 2018
Board and Executive Moves
Background Information
Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom.